CTOs on the Move

Evidation Health

www.evidation.com

 
Evidation Health is a technology and services company that helps individuals and the world`s most innovative healthcare companies understand and influence the everyday behaviors that create better health outcomes. Evidation pairs a first of its kind discovery engine designed for better, faster, and more efficient studies with a delivery platform that connects individuals and the healthcare industry, including life sciences organizations, providers, payers, and digital health companies. The company`s technology is designed to be entirely privacy-safe and individually-permissioned. Evidation Health`s mission is to enable and empower everyone to participate in better health outcomes. The company is headquartered in San Mateo, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Evidation Health raised $10M on 04/27/2017
Evidation Health raised $20M on 08/01/2018
Evidation Health raised $45M on 07/01/2020
Evidation Health raised $153M on 03/22/2021

Similar Companies

Vision Healthsource

Vision Healthsource is a Plano, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

APDA

Founded in 1961, APDA is the nations largest grassroots network dedicated to assist the more than 1 million Americans living with Parkinson’s disease.

Recombinant Data

Recombinant Data Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corazon Inc

Corazon Inc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.